Cardiovascular Diseases
PRINCIPAL INVESTIGATORS
- Albert Ariza Solé
- Cristina Enjuanes Grau
- José Luis Ferreiro Gutiérrez
- Josep Gómez Lara
- José González Costello
- Elena Iborra Ortega
- Marta Tajes Orduña
- Jordi Piera Jimenez
CLINICAL RESEARCHERS
- Ana Belén Redondo Noya
- Javier Berdejo Gago
- Joan Antoni Gómez Hospital
- Montserrat Gracida Blancas
- Raúl Ramos Polo
- Alex Ruiz Majoral
- Rodolfo Valentin San Antonio Dharandas
- Jose Carlos Sánchez Salado
- Xavier Pintó Sala
- Ramón Vila Coll
EXTERNAL COLLABORATORS
- Lídia Alcoberro Torres
- Ignasi Anguera Camos
- Ángel Cequier Fillat
- Marco Cordero
- Nicolas Manito Lorite
- Albert Miralles Cassina
POSTDOCTORAL RESEARCHERS
- Alberto Garay Melero
- María Del Carmen Basalo Carbajales
- Paolo Domenico Dallaglio
- Andrea Di Marco
- Joan Isaac Llaó Ferrando
- Pedro Moliner Borja
- Gerard Roura Ferrer
- Santiago Jiménez Marrero
- Rafael Romaguera Torres
- Guillem Muntané Carol
Jordi Castillo García
Oona Meroño Dueñas
Aleksandra Mas Stachurska
PREDOCTORAL RESEARCHERS
- Esther Calero Molina
- Carles Díez López
- Josep Francesch Manzano
- Elena Garcia Romero
- Mª Del Mar Ras Jimenez
- Jesus Sanchez Vega
- Fernando De Frutos Seminario
- Lorena Herrador Galindo
- Alexandra Pons Riverola
- Sergi Yun Viladomat
SCIENTIFIC SUPPORT
- Encarnación Hidalgo Quirós
- Laia Rosenfeld I Vilalta
- Silvia Gabriela Sosa
- Nuria José Bazán
MANAGEMENT SUPPORT
- Eva Olivera Saez
Translational Medicine
Cardiovascular, Respiratory and Systemic Diseases and cellular aging
Scientific production
174
PAPERS
Average IF: 11,374
37
LED PAPERS
Average IF: 7,859
34 PUBLICATIONS IN FIRST DECILE
66 PUBLICATIONS IN FIRST QUARTILE
104 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Jhund PS, Belohlavek J, Chiang CE, Borleffs CJW, Comin Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O’Meara E, Saraiva JFK, Tereshchenko SN, Thierer J, Vaduganathan M, Vardeny O, Verma S, Pham VN, Wilderäng U, Zaozerska N, Bachus E, Lindholm D, Petersson M, Langkilde AM, DELIVER Trial Committees and I. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N. Engl. J. Med. 2022;387(12):1089-1098. doi:10.1056/NEJMoa2206286.
- Senage T, Paul A, Le Tourneau T, Fellah Hebia I, Vadori M, Bashir S, Galinanes M, Bottio T, Gerosa G, Evangelista A, Badano LP, Nassi A, Costa C, Cesare G, Manji RA, de Monchy CC, Piriou N, Capoulade R, Serfaty JM, Guimbretiere G, Dantan E, Ruiz Majoral A, du Fou GC, Ben Arye SL, Govani L, Yehuda S, Abramovitch SB, Amon R, Reuven EM, Atiya Nasagi Y, Yu H, Iop L, Casos K, Kuguel SG, Blasco Lucas A, Permanyer E, Sbraga F, Llatjos R, Moreno Gonzalez G, Sanchez Martinez M, Breimer ME, Holgersson J, Teneberg S, Pascual Gilabert M, Nonell Canals A, Takeuchi Y, Chen X, Manez R, Roussel JC, Soulillou JP, Cozzi E, Padler Karavani V. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration. Nat. Med. 2022;28(2):283-294. doi:10.1038/s41591-022-01682-w.
- Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Tromp J, Borleffs CJW, Ma C, Comin Colet J, Fu M, Janssens SP, Kiss RG, Mentz RJ, Sakata Y, Schirmer H, Schou M, Schulze PC, Spinarova L, Volterrani M, Wranicz JK, Zeymer U, Zieroth S, Brueckmann M, Blatchford JP, Salsali A, Ponikowski P. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat. Med. 2022;28(3):568-574. doi:10.1038/s41591-021-01659-1.
- Moliner P, Comin Colet J. Iron deficiency and supplementation therapy in heart failure. Nat. Rev. Cardiol. 2022;19(9):571-572. doi:10.1038/s41569-022-00747-0.
- Kosiborod MN, Angermann CE, Collins SP, Teerlink JR, Ponikowski P, Biegus J, Comin Colet J, Ferreira JP, Mentz RJ, Nassif ME, Psotka MA, Tromp J, Brueckmann M, Blatchford JP, Salsali A, Voors AA. Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized for Acute Heart Failure – Results From the EMPULSE Trial. Circulation. 2022;146(4):279-288. doi:10.1161/CIRCULATIONAHA.122.059725.
Research highlights
PROJECTS
14 Granted competitive projects
16 Ongoing competitive projects
16 Started clinical trials
56 Ongoing clinical trials
3 Ongoing non competitive projects
PUBLISHED WORKS
3 Clinical guidelines
18 Theses
NETWORKS
CIBEROBN
CIBERCV
AGAUR SGR GRC
Selected projects
- MCI21056. Estrategias preventivas integradoras para el cáncer y las enfermedades cardiovasculares basadas en inteligencia artificial (IA ) Ministerio de Ciencia e Innovación. Budget: 569250. 2022-2024. PI: Comín Colet, Josep.
- MCI21056. TED 2021- CCSHARED – Artificial intelligence (AI) driven integrative preventive strategies for cancer and CV disease (ARTICCA). Ministerio de Ciencia e Innovación. Budget: 569250. 2022-2024. PI: Josep Comin.”
- 18ACL013. Estudio Onyx ONE; un estudio aleatorizado y controlado con el stent Resolute Onyx y tratamiento de doble antiagregación plaquetaria [DAPT] de Un mes para pacientes con alto riesgo de sangrado. Budget: 350800. 2018- . PI: Cequier Fillat, Ángel.
- 20ACL119. HELIOS-B: ESTUDIO DE FASE 3, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y MULTICÉNTRICO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE VUTRISIRÁN EN PACIENTES CON AMILOIDOSIS CARDIACA POR TRANSTIRETINA (AMILOIDOSIS POR ATTR CON MIOCARDIOPATÍA). Budget: 299745. 2020- . PI: González Costello, José.
- MCI22001. Clinical trial to evaluate the administration of ApTOLL in Acute Myocardial Infarction. APSTEMI. Ministerio de Ciencia e Innovación. Budget: 259100,89. 2022-2025. PI: Gómez Hospital, Joan Antoni.